Zaria C Ali, Nadeem Moshin, Mohamad T Hakim, Vikas Shankar
{"title":"Two-year Outcomes of XEN Implantation with Minimal Bleb Needling.","authors":"Zaria C Ali, Nadeem Moshin, Mohamad T Hakim, Vikas Shankar","doi":"10.5005/jp-journals-10078-1363","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>Our study aims to report the 2 years outcomes of the XEN implant in a single unit, single surgeon setting with minimal bleb needling.</p><p><strong>Methods: </strong>A retrospective cohort study was conducted. Inclusion criteria were patients who underwent implantation with a XEN device between May 2016 and December 2017. This included patients who underwent both combined phacoemulsification and intraocular lens implantation alongside XEN implantation and those who underwent XEN implantation alone. Data gathered included basic demographic data, best-corrected visual acuity (LogMAR), intraocular pressure (IOP) in mm Hg, mean deviation from their visual field test, and the number of IOP-lowering medications they were on. This information was recorded for their preoperative visit, and then at 6, 12, 18 and 24 months postoperatively. The primary outcome assessed was a complete success when the patient was without glaucoma medications and had an IOP of 18 mm Hg or less, but more importantly, this also had to equate to a 20% reduction in IOP compared to baseline. Qualified success was defined as the same change in IOP but with medications. Surgical failure is defined as those who required additional glaucoma surgery or those who did not obtain an IOP of 18 mm Hg alongside a 20% reduction in IOP compared to baseline.</p><p><strong>Results: </strong>At 24 months follow-up 82.5% of patients were surgical successes. Complete surgical success was achieved in 27% of patients. Qualified surgical success was achieved in 55.6% of patients. Subgroup analysis of those undergoing XEN implantation on its own and those combined with phacoemulsification + IOL were similar. The rate of bleb needling was low at 4.5%. Complication rates were acceptable at 9.5%.</p><p><strong>Conclusion: </strong>It is possible to get good IOP control with minimal postoperative bleb needling in patients who have undergone XEN implantation. Similar success rates are found in those undergoing combined procedures.</p><p><strong>Clinical significance: </strong>Bleb needling carries its own risks. Minimizing the number of bleb needling allows procedures to be reserved at a later date. Furthermore, our study shows that success rates are not affected by doing a combined procedure with phacoemulsification.</p><p><strong>How to cite this article: </strong>Ali ZC, Moshin N, Hakim MT, <i>et al.</i> Two-year Outcomes of XEN Implantation with Minimal Bleb Needling. J Curr Glaucoma Pract 2022;16(2):79-83.</p>","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"16 2","pages":"79-83"},"PeriodicalIF":0.0000,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e9/f5/jocgp-16-79.PMC9452704.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Current Glaucoma Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5005/jp-journals-10078-1363","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1
Abstract
Aim: Our study aims to report the 2 years outcomes of the XEN implant in a single unit, single surgeon setting with minimal bleb needling.
Methods: A retrospective cohort study was conducted. Inclusion criteria were patients who underwent implantation with a XEN device between May 2016 and December 2017. This included patients who underwent both combined phacoemulsification and intraocular lens implantation alongside XEN implantation and those who underwent XEN implantation alone. Data gathered included basic demographic data, best-corrected visual acuity (LogMAR), intraocular pressure (IOP) in mm Hg, mean deviation from their visual field test, and the number of IOP-lowering medications they were on. This information was recorded for their preoperative visit, and then at 6, 12, 18 and 24 months postoperatively. The primary outcome assessed was a complete success when the patient was without glaucoma medications and had an IOP of 18 mm Hg or less, but more importantly, this also had to equate to a 20% reduction in IOP compared to baseline. Qualified success was defined as the same change in IOP but with medications. Surgical failure is defined as those who required additional glaucoma surgery or those who did not obtain an IOP of 18 mm Hg alongside a 20% reduction in IOP compared to baseline.
Results: At 24 months follow-up 82.5% of patients were surgical successes. Complete surgical success was achieved in 27% of patients. Qualified surgical success was achieved in 55.6% of patients. Subgroup analysis of those undergoing XEN implantation on its own and those combined with phacoemulsification + IOL were similar. The rate of bleb needling was low at 4.5%. Complication rates were acceptable at 9.5%.
Conclusion: It is possible to get good IOP control with minimal postoperative bleb needling in patients who have undergone XEN implantation. Similar success rates are found in those undergoing combined procedures.
Clinical significance: Bleb needling carries its own risks. Minimizing the number of bleb needling allows procedures to be reserved at a later date. Furthermore, our study shows that success rates are not affected by doing a combined procedure with phacoemulsification.
How to cite this article: Ali ZC, Moshin N, Hakim MT, et al. Two-year Outcomes of XEN Implantation with Minimal Bleb Needling. J Curr Glaucoma Pract 2022;16(2):79-83.
目的:我们的研究旨在报告单个单位,单个外科医生设置最小水泡针刺的XEN种植体2年的结果。方法:采用回顾性队列研究。纳入标准为2016年5月至2017年12月期间植入XEN装置的患者。这包括联合超声乳化术和人工晶状体植入术以及XEN植入术和单独XEN植入术的患者。收集的数据包括基本人口统计学数据、最佳矫正视力(LogMAR)、眼内压(IOP)(单位:mm Hg)、视野测试的平均偏差以及他们服用的降眼压药物的数量。术前、术后6、12、18和24个月记录这些信息。评估的主要结果是,当患者没有使用青光眼药物并且IOP在18 mm Hg或以下时完全成功,但更重要的是,与基线相比,这也必须等于IOP降低20%。合格的成功被定义为相同的IOP变化,但有药物治疗。手术失败定义为需要额外青光眼手术或IOP未达到18 mm Hg且IOP较基线降低20%的患者。结果:随访24个月,82.5%的患者手术成功。27%的患者手术完全成功。手术成功率为55.6%。单独行XEN植入术与联合超声乳化+人工晶状体植入术亚组分析相似。泡针率较低,为4.5%。并发症发生率为9.5%。结论:XEN植入术患者术后小泡针刺即可获得良好的IOP控制。在接受联合手术的患者中也发现了类似的成功率。临床意义:泡针有其自身的风险。最大限度地减少泡针的数量,可以在以后的日期保留程序。此外,我们的研究表明,成功率不受联合超声乳化手术的影响。文章引用方式:Ali ZC, Moshin N, Hakim MT等。极小气泡针刺XEN植入的两年疗效。中华青光眼杂志;2009;16(2):79-83。